Skip to main content
GDU LC 2023 Main banner

  1. Home

  • Thursday, Sep 21st
    8:00 AM – 8:15 AM ET
    Welcome
    Co-Chair: Edward B. Garon, MD, MS – University of California, Los Angeles
    Co-Chair: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania
  • Thursday, Sep 21st
    8:15 AM – 9:00 AM ET
    Session 1: Birdseye View of the Current Tretatment Landscape in Metastatic NSCLC without Actionable Mutations
    Presenter: Karen Reckamp, MD – Cedars Sinai Medical Center
  • Thursday, Sep 21st
    9:00 AM – 9:45 AM ET
    Session 2: Sensitizing and Atypical EGFR Mutations
    Presenter: Gregory J. Riely, MD, PhD – Memorial Sloan Kettering Cancer Center
  • Thursday, Sep 21st
    9:45 AM – 9:50 AM ET
    Break
  • Thursday, Sep 21st
    9:50 AM – 10:50 AM ET
    Non-CME Innovation Theater - Sponsored by AstraZeneca
  • Thursday, Sep 21st
    10:50 AM – 11:00 AM ET
    Exhibit Hall
  • Thursday, Sep 21st
    11:00 AM – 11:45 AM ET
    Session 3: EGFR: The Challenge of Primary and Secondary Resistance
    Presenter: Helena Yu, MD – Memorial Sloan Kettering Cancer Center
  • Thursday, Sep 21st
    11:45 AM – 12:00 PM ET
    Session 4: Debate: Alectinib vs Lorlatinib in ALK Positive - Lorlatinib
    Debate Speaker: Misako Nagasaka, MD, PhD – University of California Irvine
  • Thursday, Sep 21st
    12:00 PM – 12:15 PM ET
    Session 4: Debate: Alectinib vs Lorlatinib in ALK Positive - Alectinib
    Debate Speaker: Ticiana Leal, MD – Emory University
  • Thursday, Sep 21st
    12:15 PM – 12:30 PM ET
    Q&A Panel
    Panelist: Ticiana Leal, MD – Emory University
    Panelist: Misako Nagasaka, MD, PhD – University of California Irvine
  • Thursday, Sep 21st
    12:30 PM – 12:35 PM ET
    Break
  • Thursday, Sep 21st
    12:35 PM – 1:35 PM ET
    Non-CME Innovation Theater - Sponsored by Sanofi
  • Thursday, Sep 21st
    1:35 PM – 2:20 PM ET
    Session 5: Unique Immune Combinations with CPIs
    Presenter: Hossein Borghaei, DO, MS – Fox Chase Cancer Center
  • Thursday, Sep 21st
    2:20 PM – 3:05 PM ET
    Session 6: Advancing the Management of NSCLC: A Focus on Emerging Therapies
    Presenter: Ticiana Leal, MD – Emory University
  • Thursday, Sep 21st
    3:05 PM – 3:35 PM ET
    Exhibit Hall
  • Thursday, Sep 21st
    3:35 PM – 4:20 PM ET
    Session 7: The Era of ADCs in the Treatment of NSCLC Part 1: Class Overview and Specifics of TROP2, HER3, c-MET, and CEACAM5 Investigational ADCs
    Presenter: Barbara Melosky, MD – Bc Cancer
  • Thursday, Sep 21st
    4:20 PM – 5:05 PM ET
    Session 8: HER2 and the Emerging Roles of HER Family ADCs
    Presenter: Helen J. Ross, MD – Rush University
  • Friday, Sep 22nd
    8:00 AM – 8:15 AM ET
    Welcome
  • Friday, Sep 22nd
    8:15 AM – 9:00 AM ET
    Session 9: The Primacy of Front-Line Checkpoint Inhibitors in NSCLC
    Presenter: Natasha Leighl, MD, FRCPC, FASCO – Princess Margaret Cancer Centre
  • Friday, Sep 22nd
    9:00 AM – 9:07 AM ET
    Session 10: Debate: How to Handle PD-L1 <1% - Chemo + IO
    Debate Speaker: Karen Reckamp, MD – Cedars Sinai Medical Center
  • Friday, Sep 22nd
    9:07 AM – 9:14 AM ET
    Session 10: Debate: How to Handle PD-L1 <1% - IO Combos
    Debate Speaker: Hossein Borghaei, DO, MS – Fox Chase Cancer Center
  • Friday, Sep 22nd
    9:14 AM – 9:21 AM ET
    Session 10: Debate: How to Handle PD-L1 1-49% - Chemo + IO
    Debate Speaker: Karen Reckamp, MD – Cedars Sinai Medical Center
  • Friday, Sep 22nd
    9:21 AM – 9:28 AM ET
    Session 10: Debate: How to Handle PD-L1 1-49% - IO Only
    Debate Speaker: Hossein Borghaei, DO, MS – Fox Chase Cancer Center
  • Friday, Sep 22nd
    9:28 AM – 9:45 AM ET
    Q&A Panel
    Panelist: Hossein Borghaei, DO, MS – Fox Chase Cancer Center
    Panelist: Karen Reckamp, MD – Cedars Sinai Medical Center
  • Friday, Sep 22nd
    9:45 AM – 9:50 AM ET
    Break
  • Friday, Sep 22nd
    9:50 AM – 10:50 AM ET
    Non-CME Innovation Theater - Sponsored by Catalyst
  • Friday, Sep 22nd
    10:50 AM – 11:00 AM ET
    Exhibit Hall
  • Friday, Sep 22nd
    11:00 AM – 11:45 AM ET
    Session 11: Fusions as a Target in Lung Cancer: RET, NTRK, NRG1, ROS1
    Presenter: Deborah Doroshow, MD, PhD – Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
  • Friday, Sep 22nd
    11:45 AM – 12:30 PM ET
    Session 12: Updates from Recent Meetings
    Presenter: Helen J. Ross, MD – Rush University
  • Friday, Sep 22nd
    12:30 PM – 1:35 PM ET
    Lunch Break
  • Friday, Sep 22nd
    1:35 PM – 1:42 PM ET
    Session 13: Debate: How to Handle PD-L1 >50% - Chemo + IO
    Presenter: Patrick Forde, MD – Johns Hopkins University
  • Friday, Sep 22nd
    1:42 PM – 1:49 PM ET
    Session 13: Debate: How to Handle PD-L1 >50% - IO Only
    Presenter: Jamie E. Chaft, MD – Memorial Sloan Kettering Cancer Center
  • Friday, Sep 22nd
    1:49 PM – 1:56 PM ET
    Session 13: Debate: Neoadjuvant vs Adjuvant Therapy - Neoadjuvant
    Presenter: Jamie E. Chaft, MD – Memorial Sloan Kettering Cancer Center
  • Friday, Sep 22nd
    1:56 PM – 2:03 PM ET
    Session 13: Debate: Neoadjuvant vs Adjuvant Therapy - Adjuvant
    Presenter: Patrick Forde, MD – Johns Hopkins University
  • Friday, Sep 22nd
    2:03 PM – 2:20 PM ET
    Q&A Panel
    Panelist: Patrick Forde, MD – Johns Hopkins University
    Panelist: Jamie E. Chaft, MD – Memorial Sloan Kettering Cancer Center
  • Friday, Sep 22nd
    2:20 PM – 3:05 PM ET
    Session 14: Targeted Therapy for MET-Dependent Lung Cancers: Have We Met Our Match?
    Presenter: Natasha Leighl, MD, FRCPC, FASCO – Princess Margaret Cancer Centre
  • Friday, Sep 22nd
    3:05 PM – 3:35 PM ET
    Exhibit Hall
  • Friday, Sep 22nd
    3:35 PM – 4:20 PM ET
    Session 15: KRAS Mutations: Taming a "Defiant" Oncogene in NSCLC
    Presenter: Joshua K. Sabari, MD – NYU Langone Health Perlmutter Cancer Center
  • Friday, Sep 22nd
    4:20 PM – 5:05 PM ET
    Session 16: BRAF Mutations: Identifying and Addressing a Rare Oncogenic Driver
    Presenter: Lyudmila Bazhenova, MD – University of California, San Diego
  • Saturday, Sep 23rd
    8:00 AM – 8:15 AM ET
    Welcome
    Co-Chair: Edward B. Garon, MD, MS – University of California, Los Angeles
  • Saturday, Sep 23rd
    8:15 AM – 9:00 AM ET
    Session 17: The Road from DNA to Protein: Navigating the Minefield of Expression Amplification and Mutation
    Presenter: Ignacio Wistuba, MD – The University of Texas MD Anderson Cancer Center
  • Saturday, Sep 23rd
    9:00 AM – 9:45 AM ET
    Session 18: The Power of Patient Advocacy
    Presenter: Kim Norris – Lung Cancer Foundation of America
  • Saturday, Sep 23rd
    9:45 AM – 10:05 AM ET
    Break
  • Saturday, Sep 23rd
    10:05 AM – 10:50 AM ET
    Session 19: Serial Monitoring Using Liquid Biopsy
    Presenter: Christian Rolfo, MD – Mount Sinai
  • Saturday, Sep 23rd
    10:50 AM – 11:35 AM ET
    Session 20: Understanding Lambert-Eaton Myasthenic Syndrome and Its Association with Small Cell Lung Cancer
    Presenter: Jennifer Carlisle, MD – Emory University Winship Cancer Institute
  • Saturday, Sep 23rd
    11:35 AM – 12:20 PM ET
    Lunch Break
  • Saturday, Sep 23rd
    12:20 PM – 1:05 PM ET
    Session 21: Finally Moving Forward in SCLC: The Pace of Progress is No Longer Glacial
    Presenter: Charles Rudin, MD, PhD – Memorial Sloan Kettering Cancer Center
  • Saturday, Sep 23rd
    1:05 PM – 1:15 PM ET
    Exhibit Hall
  • Saturday, Sep 23rd
    1:15 PM – 1:30 PM ET
    Session 22: Debate: Prophylactic Cranial Irradiation (PCI) in SCLC - Yes
    Presenter: Charles Simone, MD – Memorial Sloan Kettering Cancer Center and New York Proton Center
  • Saturday, Sep 23rd
    1:30 PM – 1:45 PM ET
    Session 22: Debate: Prophylactic Cranial Irradiation (PCI) in SCLC - No
    Presenter: Daniel Gomez, MD – Memorial Sloan Kettering Cancer Center
  • Saturday, Sep 23rd
    1:45 PM – 2:00 PM ET
    Q&A Panel
    Panelist: Daniel Gomez, MD – Memorial Sloan Kettering Cancer Center
    Panelist: Charles Simone, MD – Memorial Sloan Kettering Cancer Center and New York Proton Center
  • Saturday, Sep 23rd
    2:00 PM – 2:45 PM ET
    Session 23: How to Handle PS2 Patients and the Elderly
    Presenter: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania
  • Wednesday, Nov 29th
    2:45 PM – 3:20 PM ET
    Session 6: New Challenges of Long-Term Survival
    Presenter: Mary Fidler, MD – Rush University Medical Center
  • Wednesday, Nov 29th
    3:20 PM – 3:30 PM ET
    Live Q&A
    Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania
    Speaker: Mary Fidler, MD – Rush University Medical Center